Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.

Bliven-Sizemore EE, Sterling TR, Shang N, Benator D, Schwartzman K, Reves R, Drobeniuc J, Bock N, Villarino ME; TB Trials Consortium.

Int J Tuberc Lung Dis. 2015 Sep;19(9):1039-44, i-v. doi: 10.5588/ijtld.14.0829.

2.

Performance evaluation of a dual-flow recharge filter for improving groundwater quality.

Samuel MP, Senthilvel S, Mathew AC.

Water Environ Res. 2014 Jul;86(7):615-25.

PMID:
25112029
3.

The conformation of lipid-free human apolipoprotein A-I in solution.

Pollard RD, Fulp B, Samuel MP, Sorci-Thomas MG, Thomas MJ.

Biochemistry. 2013 Dec 31;52(52):9470-81. doi: 10.1021/bi401080k. Epub 2013 Dec 17.

4.

Fatty acid metabolites in rapidly proliferating breast cancer.

O'Flaherty JT, Wooten RE, Samuel MP, Thomas MJ, Levine EA, Case LD, Akman SA, Edwards IJ.

PLoS One. 2013 May 2;8(5):e63076. doi: 10.1371/journal.pone.0063076. Print 2013.

5.

Performance evaluation and modelling studies of gravel--coir fibre--sand multimedia stormwater filter.

Samuel MP, Senthilvel S, Tamilmani D, Mathew AC.

Environ Technol. 2012 Sep;33(16-18):2057-69.

PMID:
23240200
6.

15-lipoxygenase metabolites of docosahexaenoic acid inhibit prostate cancer cell proliferation and survival.

O'Flaherty JT, Hu Y, Wooten RE, Horita DA, Samuel MP, Thomas MJ, Sun H, Edwards IJ.

PLoS One. 2012;7(9):e45480. doi: 10.1371/journal.pone.0045480. Epub 2012 Sep 20.

7.

Cholesteryl esters associated with acyl-CoA:cholesterol acyltransferase predict coronary artery disease in patients with symptoms of acute coronary syndrome.

Miller CD, Thomas MJ, Hiestand B, Samuel MP, Wilson MD, Sawyer J, Rudel LL.

Acad Emerg Med. 2012 Jun;19(6):673-82. doi: 10.1111/j.1553-2712.2012.01378.x.

8.

Effect of HIV infection on tolerability and bacteriologic outcomes of tuberculosis treatment.

Bliven-Sizemore EE, Johnson JL, Goldberg S, Burman WJ, Villarino ME, Chaisson RE; Tuberculosis Clinical Trials Consortium.

Int J Tuberc Lung Dis. 2012 Apr;16(4):473-9. doi: 10.5588/ijtld.11.0548.

PMID:
22325844
9.

Three months of rifapentine and isoniazid for latent tuberculosis infection.

Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh CR Jr, Chaisson RE; TB Trials Consortium PREVENT TB Study Team.

N Engl J Med. 2011 Dec 8;365(23):2155-66. doi: 10.1056/NEJMoa1104875.

10.

Conformation of dimeric apolipoprotein A-I milano on recombinant lipoprotein particles.

Bhat S, Sorci-Thomas MG, Calabresi L, Samuel MP, Thomas MJ.

Biochemistry. 2010 Jun 29;49(25):5213-24. doi: 10.1021/bi1003734.

11.

Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis.

Nahid P, Bliven EE, Kim EY, Mac Kenzie WR, Stout JE, Diem L, Johnson JL, Gagneux S, Hopewell PC, Kato-Maeda M; Tuberculosis Trials Consortium.

PLoS One. 2010 May 20;5(5):e10753. doi: 10.1371/journal.pone.0010753.

12.

Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.

Dorman SE, Johnson JL, Goldberg S, Muzanye G, Padayatchi N, Bozeman L, Heilig CM, Bernardo J, Choudhri S, Grosset JH, Guy E, Guyadeen P, Leus MC, Maltas G, Menzies D, Nuermberger EL, Villarino M, Vernon A, Chaisson RE; Tuberculosis Trials Consortium.

Am J Respir Crit Care Med. 2009 Aug 1;180(3):273-80. doi: 10.1164/rccm.200901-0078OC. Epub 2009 Apr 30.

PMID:
19406981
13.

Conformational adaptation of apolipoprotein A-I to discretely sized phospholipid complexes.

Bhat S, Sorci-Thomas MG, Tuladhar R, Samuel MP, Thomas MJ.

Biochemistry. 2007 Jul 3;46(26):7811-21. Epub 2007 Jun 12.

14.

Ratio determination of plasma wild-type and L159R apoA-I using mass spectrometry: tools for studying apoA-IFin.

Owen JS, Bharadwaj MS, Thomas MJ, Bhat S, Samuel MP, Sorci-Thomas MG.

J Lipid Res. 2007 Jan;48(1):226-34. Epub 2006 Oct 28.

15.
16.

Stress-induced platelet-activating factor synthesis in human neutrophils.

Owen JS, Baker PR, O'Flaherty JT, Thomas MJ, Samuel MP, Wooten RE, Wykle RL.

Biochim Biophys Acta. 2005 Apr 15;1733(2-3):120-9. Epub 2005 Jan 14.

PMID:
15863359
17.

An improved assay for platelet-activating factor using HPLC-tandem mass spectrometry.

Owen JS, Wykle RL, Samuel MP, Thomas MJ.

J Lipid Res. 2005 Feb;46(2):373-82. Epub 2004 Nov 1.

18.

Fast food arthritis--a clinico-pathologic study of post-Salmonella reactive arthritis.

Samuel MP, Zwillich SH, Thomson GT, Alfa M, Orr KB, Brittain DC, Miller JR, Phillips PE.

J Rheumatol. 1995 Oct;22(10):1947-52.

PMID:
8991996
19.

Effect of adrenaline on plasma concentrations of bupivacaine following intra-articular injection of bupivacaine for knee arthroscopy.

Butterworth JF 4th, Carnes RS 3rd, Samuel MP, Janeway D, Poehling GG.

Br J Anaesth. 1990 Oct;65(4):537-9.

PMID:
2248822
20.

Supplemental Content

Loading ...
Support Center